ArticleJournal of orthopaedic surgery and research2025
Exosomes derived from Schwann cells (SCDE) promote tendon repair through the PTEN/PI3K/Akt signaling pathway.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exosome-mediated tendon-derived stem cell therapy strategies: potential and challenges.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tendon injury is one of the most frequently encountered soft tissue injuries with slow repair and poor functional recovery. Over the past few years, there's been a buzz about how exosomes might boost tissue repair and regeneration. This research dive delves into the question of whether Schwann cell-derived exosomes (SCDEs) can jumpstart tendon healing by tweaking the PTEN/PI3K/Akt signaling chain.been concentrated on the effects of exosomes in promoting tissue regeneration and repair. In the present study, we would like to explore whether exosomes derived from Schwann cells (SCDE) could promote tendon repair via modulation of PTEN/PI3K/Akt signaling cascade. This study integrates experiments performed both in vitro and in vivo. Tendon cells were categorized into the NC and SCDE groups, with a scratch assay employed.vitro and in vivo conditions tendo cells were divided into the NC group and SCDE group, and scratch assay, Transwell migration assay, flow cytometry for cell cycle detection, and Western blot and qRT-PCR analyses were performed to measure SCX, DCN, COL1A1, p-AKT, PTEN, and other markers.In the in vivo experiments, a rat model of 1/3 patellar tendon defect was established, and hydrogel or hydrogel + SCDE was injected. Tissues were gathered at 2, 4, and 8 weeks following the surgical procedure, and HE, Masson, and Sirius Red stains were applied to gauge the healing process. Important protein levels were assessed at the 2 week mark after the operation.Masson, and Sirius Red staining were performed to evaluate tissue repair. Key protein expression was measured at 2 weeks post-surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.